4.6

CiteScore

2.2

Impact Factor
  • ISSN 1674-8301
  • CN 32-1810/R
Monica M. Mahathre, Padmashree C. G. Rida, Ritu Aneja. The more the messier: centrosome amplification as a novel biomarker for personalized treatment of colorectal cancers[J]. The Journal of Biomedical Research, 2016, 30(6): 441-451. DOI: 10.7555/JBR.30.20150109
Citation: Monica M. Mahathre, Padmashree C. G. Rida, Ritu Aneja. The more the messier: centrosome amplification as a novel biomarker for personalized treatment of colorectal cancers[J]. The Journal of Biomedical Research, 2016, 30(6): 441-451. DOI: 10.7555/JBR.30.20150109

The more the messier: centrosome amplification as a novel biomarker for personalized treatment of colorectal cancers

More Information
  • Received Date: August 07, 2015
  • Colon cancer is currently the third most common cancer and second most fatal cancer in the United States, resulting in approximately 600,000 deaths annually. Though colorectal cancer death rates are decreasing by about 3% every year, disease outcomes could be substantially improved with more research into the drivers of colon carcinogenesis, the determinants of aggressiveness in colorectal cancer and the identification of biomarkers that could enable choice of more optimal treatments. Colon carcinogenesis is notably a slow process that can take decades. Known factors that contribute to the development of colon cancer are mutational, epigenetic and environmental, and risk factors include age, history of polyps and family history of colon cancer. Colorectal cancers exhibit heterogeneity in their features and are often characterized by the presence of chromosomal instability, microscopic satellite instability, or CpG island methylator phenotype. In this review, we propose that centrosome amplification may be a widespread occurrence in colorectal cancers and could potently influence tumor biology. Moreover, the quantitation of this cancer-specific anomaly could offer valuable prognostic information and pave the way for further customization of treatment based on the organellar profile of patients. Patient stratification models that take into account centrosomal status could thus potentially reduce adverse side effects and result in improved outcomes for colorectal cancer patients.
  • Related Articles

    [1]Izzatullo Ziyoyiddin o`g`li Abdullaev, Ulugbek Gapparjanovich Gayibov, Sirojiddin Zoirovich Omonturdiev, Sobirova Fotima Azamjonovna, Sabina Narimanovna Gayibova, Takhir Fatikhovich Aripov. Molecular pathways in cardiovascular disease under hypoxia: Mechanisms, biomarkers, and therapeutic targets[J]. The Journal of Biomedical Research. DOI: 10.7555/JBR.38.20240387
    [2]Zhang Lei, McLeod Stephanie T., Vargas Rodolfo, Liu Xiaojian, Young Dorthy K., Dobbs Thomas E.. Subgroup comparison of COVID-19 case and mortality with associated factors in Mississippi: findings from analysis of the first four months of public data[J]. The Journal of Biomedical Research, 2020, 34(6): 446-457. DOI: 10.7555/JBR.34.20200135
    [3]Pan Wei, Miyazaki Yasuo, Tsumura Hideyo, Miyazaki Emi, Yang Wei. Identification of county-level health factors associated with COVID-19 mortality in the United States[J]. The Journal of Biomedical Research, 2020, 34(6): 437-445. DOI: 10.7555/JBR.34.20200129
    [4]Alexander E. Berezin, Alexander A. Kremzer, Tatayna A. Samura. Circulating thrombospondin-2 in patients with moderate-to-severe chronic heart failure due to coronary artery disease[J]. The Journal of Biomedical Research, 2016, 30(1): 32-39. DOI: 10.7555/JBR.30.20140025
    [5]Augustine N Odili, John O Ogedengbe, Maxwell Nwegbu, Felicia O Anumah, Samuel Asala, Jan A Staessen. Nigerian Population Research on Environment, Gene and Health (NIPREGH) - objectives and protocol[J]. The Journal of Biomedical Research, 2014, 28(5): 360-367. DOI: 10.7555/JBR.28.20130199
    [6]Samuel Tate, Andrea Griem, Blythe Durbin-Johnson, Clifton Watt, Saul Schaefer. Marked elevation of B-type natriuretic peptide in patients with heart failure and preserved ejection fraction[J]. The Journal of Biomedical Research, 2014, 28(4): 255-261. DOI: 10.7555/JBR.28.20140021
    [7]Weihua Zhou, Ji Chen. I -123 metaiodobenzylguanidine imaging for predicting ventricular arrhythmia in heart failure patients[J]. The Journal of Biomedical Research, 2013, 27(6): 460-466. DOI: 10.7555/JBR.27.20130137
    [8]Shujuan Zhang, Feng Zhang, Haijian Sun, Yebo Zhou, Ying Han. Enhanced sympathetic activity and cardiac sympathetic afferent reflex in rats with heart failure induced by adriamycin[J]. The Journal of Biomedical Research, 2012, 26(6): 425-431. DOI: 10.7555/JBR.26.20120035
    [9]Xi Li, Tingzhong Wang, Ke Han, Xiaozhen Zhuo, Qun Lu, Aiqun Ma. Bisoprolol reverses down-regulation of potassium channel proteins in ventricular tissues of rabbits with heart failure[J]. The Journal of Biomedical Research, 2011, 25(4): 274-279. DOI: 10.1016/S1674-8301(11)60037-7
    [10]Sundeep?S.?Tumber, Hong?Liu. Epidural abscess after multiple lumbar punctures for labour epidural catheter placement[J]. The Journal of Biomedical Research, 2010, 24(4): 332-335. DOI: 10.1016/S1674-8301(10)60046-2
  • Cited by

    Periodical cited type(8)

    1. Guan M, Wang Y. Common variants of vitamin D receptor gene polymorphisms and risk of gastric cancer: A meta-analysis. Medicine (Baltimore), 2024, 103(35): e39527. DOI:10.1097/MD.0000000000039527
    2. Abo-Amer YE, Mohamed AA, Elhoseeny MM, et al. Association Between Vitamin D Receptor Polymorphism and the Response to Helicobacter Pylori Treatment. Infect Drug Resist, 2023, 16: 4463-4469. DOI:10.2147/IDR.S414186
    3. Liu X, Zhou Y, Zou X. Correlation between Serum 25-Hydroxyvitamin D Levels and Gastric Cancer: A Systematic Review and Meta-Analysis. Curr Oncol, 2022, 29(11): 8390-8400. DOI:10.3390/curroncol29110661
    4. Nguyen MT, Huynh NNY, Nguyen DD, et al. Vitamin D intake and gastric cancer in Viet Nam: a case-control study. BMC Cancer, 2022, 22(1): 838. DOI:10.1186/s12885-022-09933-2
    5. Kwak JH, Paik JK. Vitamin D Status and Gastric Cancer: A Cross-Sectional Study in Koreans. Nutrients, 2020, 12(7): 2004. DOI:10.3390/nu12072004
    6. Durak Ş, Gheybi A, Demirkol Ş, et al. The effects of serum levels, and alterations in the genes of binding protein and receptor of vitamin D on gastric cancer. Mol Biol Rep, 2019, 46(6): 6413-6420. DOI:10.1007/s11033-019-05088-9
    7. Kazemian E, Akbari ME, Moradi N, et al. Vitamin D Receptor Genetic Variation and Cancer Biomarkers among Breast Cancer Patients Supplemented with Vitamin D3: A Single-Arm Non-Randomized Before and After Trial. Nutrients, 2019, 11(6): 1264. DOI:10.3390/nu11061264
    8. Cai H, Jing C, Chang X, et al. Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing. J Transl Med, 2019, 17(1): 189. DOI:10.1186/s12967-019-1941-0

    Other cited types(0)

Catalog

    Article Metrics

    Article views PDF downloads Cited by(8)
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return